PKSmart: An Open-Source Computational Model to Predict in vivo Pharmacokinetics of Small Molecules
Srijit SealiD, Maria‐Anna TrapotsiiD, Vigneshwari SubramanianiD, Ola SpjuthiD, Nigel GreeneiD, Andreas BenderiD
Abstract
Drug exposure is a key contributor to the safety and efficacy of drugs. It can be defined using human pharmacokinetics (PK) parameters that affect the blood concentration profile of a drug, such as steady-state volume of distribution (VDss), total body clearance (CL), half-life (t[1/2]), fraction unbound in plasma (fu) and mean residence time (MRT). In this work, we used molecular structural fingerprints, physicochemical properties, and predicted animal PK data as features to model the human PK parameters VDss, CL, t[1/2], fu and MRT for 1,283 unique compounds. First, we predicted animal PK parameters [VDss, CL, fu] for rats, dogs, and monkeys for 372 unique compounds using molecular structural fingerprints and physicochemical properties. Second, we used Morgan fingerprints, Mordred descriptors and predicted animal PK parameters in a hyperparameter-optimised Random Forest algorithm to predict human PK parameters. When validated using repeated nested cross-validation, human VDss was best predicted with an R2 of 0.55 and a Geometric Mean Fold Error (GMFE) of 2.09; CL with accuracies of R2=0.31 and GMFE=2.43, fu with R2=0.61 and GMFE=2.81, MRT with R2=0.28 and GMFE=2.49, and t[1/2] with R2=0.31 and GMFE=2.46 for models combining Morgan fingerprints, Mordred descriptors and predicted animal PK parameters. We evaluated models with an external test set comprising 315 compounds for VDss (R2=0.33 and GMFE=2.58) and CL (R2=0.45 and GMFE=1.98). We compared our models with proprietary pharmacokinetic (PK) models from AstraZeneca and found that model predictions were similar with Pearson correlations ranging from 0.77-0.78 for human PK parameters of VDss and fu and 0.46-0.71 for animal (dog and rat) PK parameters of VDss, CL and fu. To the best of our knowledge, this is the first work that publicly releases PK models on par with industry-standard models. Early assessment and integration of predicted PK properties are crucial, such as in DMTA cycles, which is possible with models in this study based on the input of only chemical structures. We developed a webhosted application PKSmart (https://broad.io/PKSmart) which users can access using a web browser with all code also downloadable for local use. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=73 SRC="FIGDIR/small/578658v1_ufig1.gif" ALT="Figure 1"> View larger version (18K): org.highwire.dtl.DTLVardef@1a4b673org.highwire.dtl.DTLVardef@c64c5aorg.highwire.dtl.DTLVardef@bec0b3org.highwire.dtl.DTLVardef@15d5756_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOFigure:C_FLOATNO For TOC Only C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 14
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In silico PK predictions in Drug Discovery: Benchmarking of Strategies to Integrate Machine Learning with Empiric and Mechanistic PK modelling
Moritz Walter, Ghaith Aljayyoussi, … Lina Humbeck·Clinical and Translational SciencePeer-reviewed·Mar 1, 2025
- Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time Profiles
Felix Jost, Clemens Giegerich, … Henrik Cordes·CPT Pharmacometrics & Systems PharmacologyPeer-reviewed·Apr 23, 2026
- Comparison of Software for Prediction of Fraction Absorbed and Unbound in Humans
Urban Fagerholm·bioRxiv·Sep 7, 2025
- A Combination of Machine Learning and PBPK Modeling Approach for Pharmacokinetics Prediction of Small Molecules in Humans
Y. Li, Z. Wang, … L. Lai·Pharmaceutical ResearchPeer-reviewed·Jun 25, 2024
- Systematic Evaluation of High-Throughput PBK Modelling Strategies for the Prediction of Intravenous and Oral Pharmacokinetics in Humans
René Geci, Domenico Gadaleta, … Stephan Schaller·Archives of ToxicologyPeer-reviewed·May 9, 2024
- Application of mechanistic multiparameter optimization and large scale in vitro to in vivo pharmacokinetics correlations to small molecule therapeutic projects
Fabio Broccatelli, Vijayabhaskar Veeravalli, … Lei Jia·Molecular PharmaceuticsPeer-reviewed·Aug 13, 2024